PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Stefan, N.

Neues zur nichtalkoholischen Steatohepatitis.

New aspects of nonalcoholic steatohepatitis.

Internist 60, 128-132 (2019)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
During the past 10 years nonalcoholic fatty liver disease (NAFLD) has moved more and more into the focus of attention of clinical research. The term NAFLD comprises the simple nonalcoholic steatosis or fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). As the incidence of NAFLD has dramatically increased, it is expected that during the coming years NASH in particular will become the main reason for liver transplantation in industrialized countries. In addition, it has become evident that scirrhotic liver fibrosis can develop directly from NAFL without going through the stage of NASH. Finally, there is accumulating evidence that both NAFL and NASH are strongly associated with an increased risk of type2 diabetes and cardiovascular diseases and on the other hand that NAFL and NASH are complications of diabetes. This article addresses the current knowledge about the prevalence, diagnosis, risk prediction and treatment of NAFLD.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
0.427
0.162
1
1
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Review
Keywords Nonalcoholic Fatty Liver Disease ; Diabetes Mellitus ; Type2 ; Cardiovascular Diseases ; Liver Cirrhosis ; Inflammation; Fatty Liver; Progression
Language german
Publication Year 2019
HGF-reported in Year 2019
ISSN (print) / ISBN 0020-9554
e-ISSN 1432-1289
Journal Internist, Der
Quellenangaben Volume: 60, Issue: 2, Pages: 128-132 Article Number: , Supplement: ,
Publisher Springer
Publishing Place Berlin ; Heidelberg
Reviewing status Peer reviewed
Institute(s) Institute of Diabetes Research and Metabolic Diseases (IDM)
POF-Topic(s) 90000 - German Center for Diabetes Research
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502400-001
DOI 10.1007/s00108-018-0550-y
WOS ID WOS:000458169100004
Scopus ID 85060145453
PubMed ID 30645665
Erfassungsdatum 2019-03-12
[➜Report correction]